Copyright © . Transposon Therapeutics, Inc. All rights reserved. Privacy Policy Terms of Use
✕
‹ Team › Management Team
 Dennis Podlesak CEO and Chair |
 Eckard Weber, MD Chief Innovation Officer |
 Michael Cordingley, PhD Chief Scientific Officer |
 Andrew Satlin, MD Chief Medical Officer |
 Lynne Rollins Chief Financial Officer |
 Rick Orr Head, BD and Corp Counsel |
 Walter Bee, PhD SVP Preclinical & Biomarker Development |
 Mark Mugerditchian VP Manufacturing |
 Priya Jambhekar Head, Regulatory |
 Jay Soto Head, Clinical Operations |
 Ethan Geier, PhD Senior Director, Research and Development |
|